-
1
-
-
84904971641
-
Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis
-
Cazanave SC, Wang X, Zhou H, Rahmani M, Grant S, Durrant DE, Klaassen CD, Yamamoto M, Sanyal AJ. Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death Differ. 2014; 21: 1303-1312. doi: 10.1038/cdd.2014.49
-
(2014)
Cell Death Differ
, vol.21
, pp. 1303-1312
-
-
Cazanave, S.C.1
Wang, X.2
Zhou, H.3
Rahmani, M.4
Grant, S.5
Durrant, D.E.6
Klaassen, C.D.7
Yamamoto, M.8
Sanyal, A.J.9
-
2
-
-
84908202950
-
Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells
-
Wu J, Williams D, Walter GA, Thompson WE, Sidell N. Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells. Exp Cell Res. 2014; 328: 351-360. doi: 10.1016/j. yexcr.2014.08.030
-
(2014)
Exp Cell Res
, vol.328
, pp. 351-360
-
-
Wu, J.1
Williams, D.2
Walter, G.A.3
Thompson, W.E.4
Sidell, N.5
-
3
-
-
43049117465
-
Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme
-
Yoon HY, Kang NI, Lee HK, Jang KY, Park JW, Park BH. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol. 2008; 75: 2214-2223. doi: 10.1016/j.bcp.2008.02.029
-
(2008)
Biochem Pharmacol
, vol.75
, pp. 2214-2223
-
-
Yoon, H.Y.1
Kang, N.I.2
Lee, H.K.3
Jang, K.Y.4
Park, J.W.5
Park, B.H.6
-
4
-
-
33845986360
-
Chemoprotective and carcinogenic effects of tert-butylhydroquinone and its metabolites
-
Gharavi N, Haggarty S, El-Kadi AO. Chemoprotective and carcinogenic effects of tert-butylhydroquinone and its metabolites. Curr Drug Metab. 2007; 8: 1-7
-
(2007)
Curr Drug Metab
, vol.8
, pp. 1-7
-
-
Gharavi, N.1
Haggarty, S.2
El-Kadi, A.O.3
-
5
-
-
0033731182
-
Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2
-
Huang HC, Nguyen T, Pickett CB. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci USA. 2000; 97: 12475-12480. doi: 10.1073/pnas.220418997
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 12475-12480
-
-
Huang, H.C.1
Nguyen, T.2
Pickett, C.B.3
-
6
-
-
0037044791
-
Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription
-
Huang HC, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem. 2002; 277: 42769-42774. doi: 10.1074/jbc. M206911200
-
(2002)
J Biol Chem
, vol.277
, pp. 42769-42774
-
-
Huang, H.C.1
Nguyen, T.2
Pickett, C.B.3
-
7
-
-
36349030396
-
Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer
-
Kimura M, Yamamoto T, Zhang J, Itoh K, Kyo M, Kamiya T, Aburatani H, Katsuoka F, Kurokawa H, Tanaka T, Motohashi H, Yamamoto M. Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer. J Biol Chem. 2007; 282: 33681-33690. doi: 10.1074/jbc.M706863200
-
(2007)
J Biol Chem
, vol.282
, pp. 33681-33690
-
-
Kimura, M.1
Yamamoto, T.2
Zhang, J.3
Itoh, K.4
Kyo, M.5
Kamiya, T.6
Aburatani, H.7
Katsuoka, F.8
Kurokawa, H.9
Tanaka, T.10
Motohashi, H.11
Yamamoto, M.12
-
8
-
-
79851512889
-
Small molecule modulators of antioxidant response pathway
-
Hur W, Gray NS. Small molecule modulators of antioxidant response pathway. Curr Opin Chem Biol. 2011; 15: 162-173. doi: 10.1016/j. cbpa.2010.12.009
-
(2011)
Curr Opin Chem Biol
, vol.15
, pp. 162-173
-
-
Hur, W.1
Gray, N.S.2
-
9
-
-
84878596635
-
Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis
-
Gilkeson GS, Mashmoushi AK, Ruiz P, Caza TN, Perl A, Oates JC. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PLoS One. 2013; 8: e64650. doi: 10.1371/journal. pone.0064650
-
(2013)
Plos One
, vol.8
, pp. e64650
-
-
Gilkeson, G.S.1
Mashmoushi, A.K.2
Ruiz, P.3
Caza, T.N.4
Perl, A.5
Oates, J.C.6
-
10
-
-
84868628539
-
Enos deficiency predisposes podocytes to injury in diabetes
-
Yuen DA, Stead BE, Zhang Y, et al. eNOS deficiency predisposes podocytes to injury in diabetes. J Am Soc Nephrol. 2012; 23: 1810-1823
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 1810-1823
-
-
Yuen, D.A.1
Stead, B.E.2
Zhang, Y.3
-
11
-
-
84856088042
-
Asymmetric dimethylarginine and reactive oxygen species: Unwelcome twin visitors to the cardiovascular and kidney disease tables
-
Wilcox CS. Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension. 2012; 59: 375-381. doi: 10.1161/HYPERTENSIONAHA.111.187310
-
(2012)
Hypertension
, vol.59
, pp. 375-381
-
-
Wilcox, C.S.1
-
12
-
-
34748915802
-
Isoform-specific regulation by n(g),n(g)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/no
-
Wang D, Gill P, Chabrashvili T, et al. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO. Circ Res. 2007; 101: 627-635
-
(2007)
Circ Res
, vol.101
, pp. 627-635
-
-
Wang, D.1
Gill, P.2
Chabrashvili, T.3
-
13
-
-
0037399439
-
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
-
Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003; 111: 1201-1209. doi: 10.1172/JCI14172
-
(2003)
J Clin Invest
, vol.111
, pp. 1201-1209
-
-
Landmesser, U.1
Dikalov, S.2
Price, S.R.3
McCann, L.4
Fukai, T.5
Holland, S.M.6
Mitch, W.E.7
Harrison, D.G.8
-
14
-
-
78149342127
-
Chronic nitric oxide deficiency and progression of kidney disease after renal mass reduction in the C57Bl6 mouse
-
Muller V, Tain YL, Croker B, Baylis C. Chronic nitric oxide deficiency and progression of kidney disease after renal mass reduction in the C57Bl6 mouse. Am J Nephrol. 2010; 32: 575-580. doi: 10.1159/000322106
-
(2010)
Am J Nephrol
, vol.32
, pp. 575-580
-
-
Muller, V.1
Tain, Y.L.2
Croker, B.3
Baylis, C.4
-
15
-
-
79959798838
-
Stabilization of Nrf2 by tBHQ prevents LPSinduced apoptosis in differentiated PC12 cells
-
Khodagholi F, Tusi SK. Stabilization of Nrf2 by tBHQ prevents LPSinduced apoptosis in differentiated PC12 cells. Mol Cell Biochem. 2011; 354: 97-112. doi: 10.1007/s11010-011-0809-2
-
(2011)
Mol Cell Biochem
, vol.354
, pp. 97-112
-
-
Khodagholi, F.1
Tusi, S.K.2
-
16
-
-
84890946148
-
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease
-
De Zeeuw D, Akizawa T, Audhya P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med. 2013; 369: 2492-2503
-
(2013)
N Engl J Med
, vol.369
, pp. 2492-2503
-
-
De Zeeuw, D.1
Akizawa, T.2
Audhya, P.3
-
17
-
-
0033917346
-
Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism
-
Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 2000; 57: 405-413. doi: 10.1046/j.1523-1755.2000.00860.x
-
(2000)
Kidney Int
, vol.57
, pp. 405-413
-
-
Zanchi, A.1
Moczulski, D.K.2
Hanna, L.S.3
Wantman, M.4
Warram, J.H.5
Krolewski, A.S.6
-
18
-
-
70450245459
-
Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study
-
Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M, Gesualdo L, Boeger R, Zoccali C. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. Atherosclerosis. 2009; 207: 541-545. doi: 10.1016/j. atherosclerosis.2009.05.011
-
(2009)
Atherosclerosis
, vol.207
, pp. 541-545
-
-
Aucella, F.1
Maas, R.2
Vigilante, M.3
Tripepi, G.4
Schwedhelm, E.5
Margaglione, M.6
Gesualdo, L.7
Boeger, R.8
Zoccali, C.9
-
19
-
-
39449084717
-
The endothelium as a target in renal diseases
-
Zoccali C. The endothelium as a target in renal diseases. J Nephrol. 2007; 20(suppl 12): S39-S44
-
(2007)
J Nephrol
, vol.20
, pp. S39-S44
-
-
Zoccali, C.1
-
20
-
-
84906794864
-
Endothelial NADPH oxidases: Which NOX to target in vascular disease?
-
Drummond GR, Sobey CG. Endothelial NADPH oxidases: which NOX to target in vascular disease?. Trends Endocrinol Metab. 2014; 25: 452-463. doi: 10.1016/j.tem.2014.06.012
-
(2014)
Trends Endocrinol Metab
, vol.25
, pp. 452-463
-
-
Drummond, G.R.1
Sobey, C.G.2
-
21
-
-
77955964034
-
Angiotensin II and nadph oxidase increase adma in vascular smooth muscle cells
-
Luo Z, Teerlink T, Griendling K, Aslam S, Welch WJ, Wilcox CS. Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells. Hypertension. 2010; 56: 498-504. doi: 10.1161/HYPERTENSIONAHA.110.152959
-
(2010)
Hypertension
, vol.56
, pp. 498-504
-
-
Luo, Z.1
Teerlink, T.2
Griendling, K.3
Aslam, S.4
Welch, W.J.5
Wilcox, C.S.6
-
22
-
-
84869043780
-
The predicted molecular weight of Nrf2: It is what it is not
-
Lau A, Tian W, Whitman SA, Zhang DD. The predicted molecular weight of Nrf2: it is what it is not. Antioxid Redox Signal. 2013; 18: 91-93. doi: 10.1089/ars.2012.4754
-
(2013)
Antioxid Redox Signal
, vol.18
, pp. 91-93
-
-
Lau, A.1
Tian, W.2
Whitman, S.A.3
Zhang, D.D.4
-
23
-
-
79956121323
-
Nrf2 regulates hyperoxia-induced nox4 expression in human lung endothelium: Identification of functional antioxidant response elements on the nox4 promoter
-
Pendyala S, Moitra J, Kalari S, Kleeberger SR, Zhao Y, Reddy SP, Garcia JG, Natarajan V. Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: identification of functional antioxidant response elements on the Nox4 promoter. Free Radic Biol Med. 2011; 50: 1749-1759. doi: 10.1016/j.freeradbiomed.2011.03.022
-
(2011)
Free Radic Biol Med
, vol.50
, pp. 1749-1759
-
-
Pendyala, S.1
Moitra, J.2
Kalari, S.3
Kleeberger, S.R.4
Zhao, Y.5
Reddy, S.P.6
Garcia, J.G.7
Natarajan, V.8
-
24
-
-
84855453637
-
Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of ccaat/enhancer-binding protein β during adipogenesis
-
Hou Y, Xue P, Bai Y, Liu D, Woods CG, Yarborough K, Fu J, Zhang Q, Sun G, Collins S, Chan JY, Yamamoto M, Andersen ME, Pi J. Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis. Free Radic Biol Med. 2012; 52: 462-472. doi: 10.1016/j. freeradbiomed.2011.10.453
-
(2012)
Free Radic Biol Med
, vol.52
, pp. 462-472
-
-
Hou, Y.1
Xue, P.2
Bai, Y.3
Liu, D.4
Woods, C.G.5
Yarborough, K.6
Fu, J.7
Zhang, Q.8
Sun, G.9
Collins, S.10
Chan, J.Y.11
Yamamoto, M.12
Andersen, M.E.13
Pi, J.14
-
25
-
-
77956624262
-
Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice
-
Cho HY, Gladwell W, Wang X, Chorley B, Bell D, Reddy SP, Kleeberger SR. Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med. 2010; 182: 170-182. doi: 10.1164/rccm.200907-1047OC
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 170-182
-
-
Cho, H.Y.1
Gladwell, W.2
Wang, X.3
Chorley, B.4
Bell, D.5
Reddy, S.P.6
Kleeberger, S.R.7
-
26
-
-
84863696819
-
Submaximal PPARγ activation and endothelial dysfunction: New perspectives for the management of cardiovascular disorders
-
Balakumar P, Kathuria S. Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders. Br J Pharmacol. 2012; 166: 1981-1992. doi: 10.1111/j.1476-5381.2012.01938.x
-
(2012)
Br J Pharmacol
, vol.166
, pp. 1981-1992
-
-
Balakumar, P.1
Kathuria, S.2
-
27
-
-
34748915802
-
Isoform-specific regulation by n(g),n(g)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/no
-
Wang D, Gill PS, Chabrashvili T, et al. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO. Circ Res. 2007; 101: 627-635
-
(2007)
Circ Res
, vol.101
, pp. 627-635
-
-
Wang, D.1
Gill, P.S.2
Chabrashvili, T.3
-
28
-
-
33847662338
-
Asymmetric dimethyl-arginine (adma) response to inflammation in acute infections
-
Zoccali C, Maas R, Cutrupi S, Pizzini P, Finocchiaro P, Cambareri F, Panuccio V, Martorano C, Schulze F, Enia G, Tripepi G, Boger R. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant. 2007; 22: 801-806. doi: 10.1093/ndt/gfl719
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 801-806
-
-
Zoccali, C.1
Maas, R.2
Cutrupi, S.3
Pizzini, P.4
Finocchiaro, P.5
Cambareri, F.6
Panuccio, V.7
Martorano, C.8
Schulze, F.9
Enia, G.10
Tripepi, G.11
Boger, R.12
-
29
-
-
70350048649
-
Cellular adma regulation and action
-
Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: regulation and action. Pharmacol Res. 2009; 60: 448-460. doi: 10.1016/j. phrs.2009.08.002
-
(2009)
Pharmacol Res
, vol.60
, pp. 448-460
-
-
Teerlink, T.1
Luo, Z.2
Palm, F.3
Wilcox, C.S.4
-
30
-
-
84864409678
-
Regulatory role of keap1 and nrf2 in ppargamma expression and chemoresistance in human non-small-cell lung carcinoma cells
-
Zhan L, Zhang H, Zhang Q, et al. Regulatory role of KEAP1 and NRF2 in PPARgamma expression and chemoresistance in human non-small-cell lung carcinoma cells. Free Radic Biol Med. 2012; 53: 758-768
-
(2012)
Free Radic Biol Med
, vol.53
, pp. 758-768
-
-
Zhan, L.1
Zhang, H.2
Zhang, Q.3
-
31
-
-
84859762514
-
PPARγ and oxidative stress: Con(β) catenating nrf2 and foxo
-
Polvani S, Tarocchi M, Galli A. PPARγ and oxidative stress: Con(β) catenating NRF2 and FOXO. PPAR Res. 2012; 2012: 641087. doi: 10.1155/2012/641087
-
(2012)
Ppar Res
, vol.2012
, pp. 641087
-
-
Polvani, S.1
Tarocchi, M.2
Galli, A.3
-
32
-
-
38349070335
-
Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease
-
Wang D, Strandgaard S, Borresen ML, Luo Z, Connors SG, Yan Q, Wilcox CS. Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2008; 51: 184-191. doi: 10.1053/j.ajkd.2007.09.020
-
(2008)
Am J Kidney Dis
, vol.51
, pp. 184-191
-
-
Wang, D.1
Strandgaard, S.2
Borresen, M.L.3
Luo, Z.4
Connors, S.G.5
Yan, Q.6
Wilcox, C.S.7
-
33
-
-
61949358942
-
Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension
-
Wang D, Strandgaard S, Iversen J, Wilcox CS. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol. 2009; 296: R195-R200. doi: 10.1152/ajpregu.90506.2008
-
(2009)
Am J Physiol Regul Integr Comp Physiol
, vol.296
, pp. R195-R200
-
-
Wang, D.1
Strandgaard, S.2
Iversen, J.3
Wilcox, C.S.4
-
34
-
-
79960855656
-
Bardoxolone methyl and kidney function in CKD with type 2 diabetes
-
BEAM Study Investigators
-
Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG; BEAM Study Investigators. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med. 2011; 365: 327-336. doi: 10.1056/NEJMoa1105351
-
(2011)
N Engl J Med
, vol.365
, pp. 327-336
-
-
Pergola, P.E.1
Raskin, P.2
Toto, R.D.3
Meyer, C.J.4
Huff, J.W.5
Grossman, E.B.6
Krauth, M.7
Ruiz, S.8
Audhya, P.9
Christ-Schmidt, H.10
Wittes, J.11
Warnock, D.G.12
|